Limba
Romanian
Romanian
English|
Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266), 1mg*5
6.475,98 RON
SKU
SKM_A2697_1mg*5
Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD.
| Price | 5.442,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Enavatuzumab (Anti-TNFRSF12A / TWEAKR / CD266) is a humanized monoclonal antibody directed against the tumor necrosis factor-like weak inducer of apoptosis receptor (TWEAKR) with potential antineoplastic, immunomodulating and antiangiogenic activities. MW : 150 kD. |
